GlassScriptPhysician profile
Mohammad R Neal
NPI 1811057821
$14,881.44
in general payments reported to CMS, 2019-2025
18 companies · $313 in 2025
The $313 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,362 · 2020: $247 · 2021: $406 · 2022: $225 · 2023: $277 · 2024: $10K · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $9,756 · Food and Beverage: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $9,756.40 |
| Food and Beverage | $886.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $9,774.91 | 2019-2024 | Panoramic Ophthalmoscope |
| Alcon Vision LLC | $3,377.88 | 2019-2025 | Argos, Clareon, Rocklatan |
| Allergan, INC. | $524.01 | 2019-2022 | |
| Abbvie INC. | $247.55 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $180.07 | 2020-2023 | Cequa |
| Novartis Pharmaceuticals Corporation | $167.23 | 2019-2022 | |
| Dompe US, INC. | $164.77 | 2024-2025 | Oxervate |
| Horizon Therapeutics Plc | $130.40 | 2022-2023 | Tepezza |
| Rxsight INC | $98.92 | 2022-2024 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Sight Sciences, INC. | $42.66 | 2021 | |
| Thea Pharma INC. | $39.10 | 2023 | Iyuzeh |
| Omeros Corporation | $24.38 | 2021 | |
| Alcon Research LLC | $24.09 | 2019 | |
| Oyster Point Pharma, INC. | $22.45 | 2024 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $16.34 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $16.15 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $16.13 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $14.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Neal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.